Displaying 101 - 120 news posts of 126
Undergrads showcase their summer research at NeURO poster session
Stanford undergraduates and local community college students presented their summer research projects in Wu Tsai Neurosciences Institute labs at a poster session last month.
Blood Cells Mutated in Old Age Protect Against Alzheimer’s Disease
Pathologist Siddhartha Jaiswal discovers a surprising twist to our biology: age-related mutations that increase the risk of blood disease also protect against brain disease.
Seeking better treatments for preterm babies in the “second brain”
Researchers with Stanford’s Wu Tsai Neurosciences Institute aim to improve gut motility and health outcomes for preterm babies through foundational research on the nervous system of the gut, called the enteric nervous system (ENS).
Exercise and the brain
In this episode, chemist Jonathan Z. Long discusses his recent discovery of a new molecule produced when we exercise that appears to be linked to health benefits from regulating appetite to boosting learning and memory.
Psychiatry 3.0
In this episode, psychiatrist Nolan Williams discusses transcranial magnetic stimulation for major depressino and its implications for the future of psychiatry on “From Our Neurons to Yours”, a podcast from the Wu Tsai Neurosciences Institute.
Brain Fog
In this episode, neuroscientist and pediatric oncologist Michelle Monje helps us understand the mystery of the persistent "brain fog" that often plagues Long COVID patients.
Unraveling how seizures change brain insulation
Gustavo Chau Loo Kung, a Stanford Interdisciplinary Graduate Fellow and member of the Center for Mind, Brain Computation, and Technology (MBCT) at the Wu Tsai Neurosciences Institute, uses experimental MRI to investigate how myelin changes with repeated seizures.
Assembling the brain
New techniques for growing human brain tissue in the lab are fueling a revolution in scientists' ability to observe human brain development, trace the origins of psychiatric disorders and develop new treatments. Featuring Stanford psychiatry professor Sergiu Pasca.
Translating neuroscience advances to real-world uses
The Wu Tsai Neurosciences Institute and Stanford Byers Center for Biodesign are pleased to announce their fifth round of Neuroscience:Translate awards, which support teams of researchers collaborating across disciplinary boundaries.
Brain Rejuvenation
Will we soon be able to rejuvenate our brains? We talked with Tony Wyss-Coray, the director of the Knight Initiative for Brain Resilience at Wu Tsai Neuro, to learn more.
Research projects link neuroscience and AI to advance human health
The Wu Tsai Neurosciences Institute and Institute for Human-Centered Artificial Intelligence (HAI) at Stanford are pleased to announce their first year of Neuroscience and AI awards, which support ambitious proposals that reimagine the ways in which t
Respect your biological clock
Institute affiliate Erin Gibson explains why we should pay attention to our circadian rhythms.
Is addiction a disease?
Institute affiliate Keith Humphreys explains why we think of addiction as a disease.
The Mystery of Migraines
Graduate student Gabriella Muwanga answers: "What are migraines, and why are they so hard to treat?"
Wu Tsai Neuro & Knight Initiative announce 2023 postdoctoral scholars
Interdisciplinary Postdocs and Brain Resilience Scholars will advance knowledge of brain health and aging.
Psychedelics and Empathy
Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?"
The rebirth of psychedelic medicine
Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Bold ideas to advance healthy brain aging win inaugural Knight Initiative grants
The Phil and Penny Knight Initiative for Brain Resilience is proud to announce the recipients of its inaugural 2022 Innovation and Catalyst Grants.
Preprint Alert: New liquid biomarker for Parkinson's disease
Knight Initiative researchers report that they identified novel molecular markers capable of tracking the progression of Parkinson’s disease.
Social aversion during opioid withdrawal reflects blocked serotonin cues, mouse study finds
Neuroscientist Robert Malenka and his team have identified a molecular link between opioid withdrawal and social aversion in the brains of mice—suggesting the potential to help people in recovery from opioid addiction reconnect with their social support.